• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Day 2 Recap: 2024 Society for Pediatric Dermatology Annual Meeting

News
Article

Catch up on coverage from the second day of the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada.

SPD Day 2 conference recap

To stay informed with the latest conference insights, subscribe to receive our E-newsletters.

Hydrophilic Polymer, Potassium Ferrate 'WoundSeal' is Effective Alternative to Suturing in Punch Biopsies

Use of WoundSeal yielded no observed complications such as infection or bleeding, according to a poster presented at the SPD's annual meeting.

The Dermatologist’s Guide to Systemic Clues: Highlights from the Hurwitz Lecture

Lisa Weibel, MD, delved into skin signs of systemic diseases in the first of 2 Hurwitz lectures to be presented at the SPD's annual meeting.

Peter Lio, MD: Delving Into Disease Progression in Pediatric Atopic Dermatitis

Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.

Timothy Caulfield, JD: Addressing Misinformation in the Health Care Space

Caulfield discusses his SPD 2024 lecture, "The Misinformation Crisis: How Did We Get Here and What Can We Do?"

Breaking Down Inflammatory Hair Disorders in Children

Marissa Joseph, MD, discussed inflammatory hair disorders in young children, such as CCCA, in a presentation at the SPD's annual meeting.

Amy Paller, MD: Reviewing Top Insights for Clinical Practice From ESPD

Paller discusses her SPD 2024 lecture, "Updates from ISSVA, ESPD, and SID: What You Missed that Could Change Your Practice."

Preliminary Data on Therapy-Free Remission with Dupilumab for Pediatric Atopic Dermatitis

A significant proportion of pediatric patients with AD achieved and maintained clinical remission with dupilumab, according to a poster presented at the SPD's annual meeting.

To view all conference coverage from SPD, click here.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.